Your search returned 114 studies. (Get alerts for new studies):
- Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
1 Location available
- Rituximab and Pegfilgrastim in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- A Study to Evaluate the Use of the Drug Combination Vorinostat, Niacinamide, and Etoposide in Patients With Lymphoid Malignancies That Have Reoccurred
Conditions: Hodgkin's Disease - Non-Hodgkin's Lymphoma
1 Location available
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Conditions: Non-Hodgkin's Lymphoma - Leukemia - Multiple Myeloma - Myeloproliferative Disorder
1 Location available
- SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma
2 Locations available
- Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From A Normal HLA- Compatible Or Partially- Matched Third-Party Donor in the Tr
Conditions: Non-Hodgkin's Lymphoma - Epstein-Barr Virus
1 Location available
- Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Genetic Epidemiology of Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin - Leukemia, Lymphocytic, Chronic, B-Cell - Lymphoma, B-Cell
1 Location available
- Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Conditions: T Cell Non-Hodgkin Lymphoma
1 Location available
- A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Ind
Conditions: Non-Hodgkin's Lymphoma
10 Locations available
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
11 Locations available
- Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL
Conditions: Non Hodgkin's Lymphoma - NHL - Aggressive NHL
3 Locations available
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
6 Locations available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma - Solid Tumour
1 Location available
- A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Hematologic Malignancies - Acute Leukemia - Myelodysplastic Syndrome (MDS) - Specific Subtypes of Refractory Anemia (RA) or Refractory Anemia With Ringed Sideroblasts(RARS) Subtypes - Myeloproliferative Disorder (MPD) - Hodgkin's Lymphoma - Non-Hodgkin's
1 Location available
- Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Ly
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
2 Locations available
- Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic - AML - Leukemia, Lymphocytic, Acute - MDS - Leukemia, Lymphocytic, Chronic - JMML - Hodgkin's Disease - Non-hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
4 Locations available
- Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Lung Cancer - Melanoma - Non-Hodgkin's Lymphoma - Uterine Cancer - CORPUS UTERI,ENDOMETRIUM - LUNG - OVARY
1 Location available
- Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
Conditions: Hodgkin's Disease - Non Hodgkin's Lymphoma - Myeloma - Leukemia - Myelodysplasia
1 Location available
- Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse La
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Conditions: Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 kg
Conditions: Non-Hodgkin's Lymphoma
9 Locations available
- Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Conditions: Hodgkin's Lymphoma - Leukemia - Myelodysplastic Syndrome(MDS) - Multiple Myeloma - Non Hodgkin's Lymphoma
1 Location available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
Conditions: Cutaneous T Cell Lymphoma - Hodgkin's Disease - Neoplasm - Non Hodgkin's Lymphoma - Peripheral T Cell Lymphoma
1 Location available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
- A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Conditions: Hematologic Malignancy - Leukemia - Acute Lymphoblastic Leukemia - ALL - Acute Myelogenous Leukemia - AML - Chronic Lymphocytic Leukemia - CLL - Lymphoma - Hodgkin's Lymphoma - Non-hodgkin's Lymphoma - Myeloma
1 Location available
- Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Disease - Leukemia, Lymphocytic, Chronic - Lymphoproliferative Disorders
1 Location available
- Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
Conditions: Non-Hodgkin's Lymphoma
4 Locations available
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lym
Conditions: Leukemia - Lymphoma
1 Location available
- A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
Conditions: Cancer - Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Trans
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Acute Lymphocytic Leukemia - Relapsed/Refractory Chronic Lymphocytic Leukemia - Relapsed/Refractory Non Hodgkin's Lymphoma - Hodgkins Disease - Relapsed Refractory Multiple Myeloma
2 Locations available
- Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
Conditions: Multiple Myeloma - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Non Hodgkin's Lymphoma - Waldenstroms - Mantle Cell Lymphoma
1 Location available
- Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy
Conditions: Non-Hodgkin's Lymphoma
2 Locations available
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
1 Location available
- Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
10 Locations available
- A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Conditions: Lymphoma - Non-Hodgkin's Lymphoma - Hodgkin Disease - Multiple Myeloma - Leukemia - Lymphocytic - Chronic
5 Locations available
- High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
Conditions: Non-Hodgkin's Lymphoma - CNS Lymphoma
2 Locations available
- PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
Conditions: Non-Hodgkin's Lymphoma - Active Solid Malignancy
1 Location available
- AMG 319 Lymphoid Malignancy FIH
Conditions: Cancer - Chronic Lymphocytic Leukemia - Diffuse Large Cell Lymphoma - Hematologic Malignancies - Hematology - Leukemia - Low Grade Lymphoma - Lymphoma - Mantle Cell Lymphoma - Non-Hodgkin's Lymphoma - Oncology - Oncology Patients - T Cell Lymphoma - Tumor
2 Locations available
- Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma
3 Locations available
- Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Conditions: Chronic Lymphocytic Leukemia - B-Cell Non-Hodgkin's Lymphoma
1 Location available
- Reduced Intensity Double Umbilical Cord Blood Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma - Chronic Lymphocytic Leukemia - Acute Myelogenous Leukemia
2 Locations available
- Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Topical Romidepsin in Treating Patients With Stage I or Stage II Cutaneous T-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS - AML - Solid Tumors - Multiple Myeloma - Non-Hodgkin's Lymphoma - Hodgkin's Disease
8 Locations available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
8 Locations available
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, Follicular
6 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Mantle
1 Location available
- A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hod
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
4 Locations available
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
13 Locations available
- Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment
Conditions: Solid Tumors - Lymphoma
1 Location available
- Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Conditions: Non Hodgkin's Lymphoma
1 Location available
- Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies - Acute Myeloid Leukemia - Lymphoid Leukemia - Chronic Myeloid Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndromes
12 Locations available
- CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Conditions: Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
3 Locations available
- Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma - Chronic Lymphocytic Leukemia
2 Locations available
- A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
1 Location available
- Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
1 Location available
- Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantat
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemias - Multiple Myeloma With Plasmacytoma
1 Location available
- Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
Conditions: High Risk Non-Hodgkin's Lymphoma
1 Location available
- A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Conditions: Non-Hodgkin's Lymphoma
9 Locations available
- Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin'
Conditions: Non-Hodgkin's Lymphoma - Mantle Cell Lymphoma
27 Locations available
- Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Tr
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
Conditions: Lymphoma, Non-Hodgkin
9 Locations available
- A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With MabThera/Rituxan (Rituximab) Plus Chemotherapy Followed by GA101 or MabThera/
Conditions: Non-Hodgkin's Lymphoma
5 Locations available
- Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases
Conditions: Chronic Leukemia - Acute Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndrome
1 Location available
- Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent G
1 Location available
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
79 Locations available
- Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Conditions: Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Lenalidomide Plus Rituximab for Indolent Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Autologous and Allogeneic Transplant for Relapsed Lymphoma
Conditions: Non-Hodgkin's Lymphoma - Hodgkins Disease
1 Location available
- Effectiveness of a Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN #0701
Conditions: Lymphoma, Non-Hodgkin
34 Locations available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- Host Dendritic Cells in Allograft Patients
Conditions: Relapsed Non-Hodgkin's Lymphoma - Hodgkin's Disease - Multiple Myeloma - Chronic Lymphocytic Lymphoma
1 Location available
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
9 Locations available
- A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
5 Locations available
- Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
Conditions: Non-Hodgkin's Lymphoma - B-cell Lymphoma
1 Location available
- Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
Conditions: Non Hodgkin's Lymphoma
1 Location available
- A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood - Hodgkin's Disease - Non-Hodgkin's Lymphoma
1 Location available
- Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple M
Conditions: Solid Tumors - Non-Hodgkin's Lymphoma - Multiple Myeloma
2 Locations available
- IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
Conditions: AIDS Related Lymphoma - HIV Infection
1 Location available
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
2 Locations available
- Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma
3 Locations available
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
227 Locations available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic C
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Myelofibrosis - MDS - Refractory Anemia - Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Multiple Myeloma - Non-Hodgkin's Lymphoma - Leukemia - Lymphoma - Multi
1 Location available
- Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Conditions: Lymphoma, Non-Hodgkin - Hodgkin's Disease
1 Location available
- Spectroscopy With Surface Coils and Decoupling
Conditions: Adrenal Cortical Cancer - Brain Cancer - Breast Cancer - CNS Cancer - Colon Cancer - HEENT Cancer - Hodgkin's Disease - Kaposi's Sarcoma - Liver Cancer - Lung Cancer - Non-Hodgkin's Lymphoma - Ovarian Cancer - Pancreatic Cancer - Prostate Cancer - Rectal
1 Location available
- CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia
Conditions: Lymphoma - Leukemia
3 Locations available
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
2 Locations available
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-
Conditions: Renal Cell Carcinoma - Non-hodgkin's Lymphoma
5 Locations available
- Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
3 Locations available
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
2 Locations available
- Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
Conditions: Non-Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Unrelated Donor Stem Cell Transplantation
Conditions: Severe Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndromes - Myeloproliferative Syndromes - Chronic Myelogenous Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphom
1 Location available
|